Matches in SemOpenAlex for { <https://semopenalex.org/work/W2078227270> ?p ?o ?g. }
- W2078227270 endingPage "442" @default.
- W2078227270 startingPage "434" @default.
- W2078227270 abstract "In spite of treatment, severe angioproliferative pulmonary arterial hypertension (PAH) remains a disease characterized by great morbidity and shortened survival. New treatment strategies for patients with PAH are needed, and after drug development, preclinical studies are best conducted in animal models which present with pulmonary angio‐obliterative disease and right heart failure. A rat model of severe pulmonary hypertension and right heart failure, described a decade ago, continues to be investigated and provide insight into the nature of the lung vascular lesions and mechanisms of cardiac adaptation to an altered lung circulation. This rat model is based on the combination of VEGF receptor blockade with Su5416 and chronic hypoxia; use of this pulmonary hypertension induction strategy led to developing the concept of apoptosis‐dependent compensatory vascular cell growth. Although, often employed in experimental designs, chronic hypoxia is not necessary for the development of angio‐obliterative pulmonary hypertension. Left pneumonectomy combined with Su5416 also results in severe pulmonary hypertension in normoxic conditions. Similarly, the immune insufficiency component of severe PAH can be modeled in athymic rats (lacking T‐lymphocytes). In these rats housed under normoxic conditions, treatment with the VEGFR receptor blocker results in angioproliferative pulmonary hypertension; cardiopulmonary disease in these animals can be prevented by immune reconstitution of regulatory T‐cells (Tregs). Finally, chronic hypoxia can be replaced with another stimulator of HIF‐1α: Ovalbumin (Ova). Immunization of rats with Ova increases lung tissue HIF‐1α protein expression, and in Su5416‐treated rats causes lethal pulmonary hypertension. Finally, we postulate that these models may also be useful for “reverse translation”; that is, the mechanisms of lung vascular cell death and growth and the modifying influences of immune and bone marrow cells that have been identified in the Su5416 VEGFR inhibitor models can be informative about heretofore undescribed processes in human PAH." @default.
- W2078227270 created "2016-06-24" @default.
- W2078227270 creator A5031013450 @default.
- W2078227270 creator A5047479690 @default.
- W2078227270 creator A5053967967 @default.
- W2078227270 creator A5064911466 @default.
- W2078227270 creator A5066924143 @default.
- W2078227270 creator A5073219125 @default.
- W2078227270 creator A5075176144 @default.
- W2078227270 creator A5083704139 @default.
- W2078227270 creator A5084022307 @default.
- W2078227270 date "2012-10-01" @default.
- W2078227270 modified "2023-10-17" @default.
- W2078227270 title "New Models of Pulmonary Hypertension Based on VEGF Receptor Blockade‐Induced Endothelial Cell Apoptosis" @default.
- W2078227270 cites W1968506780 @default.
- W2078227270 cites W1971455632 @default.
- W2078227270 cites W1979514142 @default.
- W2078227270 cites W1982661764 @default.
- W2078227270 cites W1993519783 @default.
- W2078227270 cites W2002393978 @default.
- W2078227270 cites W2011647595 @default.
- W2078227270 cites W2012675069 @default.
- W2078227270 cites W2014217144 @default.
- W2078227270 cites W2016054079 @default.
- W2078227270 cites W2017027000 @default.
- W2078227270 cites W2026368238 @default.
- W2078227270 cites W2036078467 @default.
- W2078227270 cites W2037896891 @default.
- W2078227270 cites W2038963002 @default.
- W2078227270 cites W2040283898 @default.
- W2078227270 cites W2041193111 @default.
- W2078227270 cites W2041865472 @default.
- W2078227270 cites W2044905529 @default.
- W2078227270 cites W2045826243 @default.
- W2078227270 cites W2046455986 @default.
- W2078227270 cites W2054084651 @default.
- W2078227270 cites W2054154232 @default.
- W2078227270 cites W2061358741 @default.
- W2078227270 cites W2062002285 @default.
- W2078227270 cites W2070507117 @default.
- W2078227270 cites W2073791430 @default.
- W2078227270 cites W2074461681 @default.
- W2078227270 cites W2077805959 @default.
- W2078227270 cites W2079275932 @default.
- W2078227270 cites W2087780523 @default.
- W2078227270 cites W2090134402 @default.
- W2078227270 cites W2091892364 @default.
- W2078227270 cites W2095002343 @default.
- W2078227270 cites W2098180530 @default.
- W2078227270 cites W2098368231 @default.
- W2078227270 cites W2099912088 @default.
- W2078227270 cites W2101927102 @default.
- W2078227270 cites W2103763164 @default.
- W2078227270 cites W2106846696 @default.
- W2078227270 cites W2107763047 @default.
- W2078227270 cites W2111228991 @default.
- W2078227270 cites W2123475727 @default.
- W2078227270 cites W2131898896 @default.
- W2078227270 cites W2136089486 @default.
- W2078227270 cites W2136978968 @default.
- W2078227270 cites W2137884826 @default.
- W2078227270 cites W2139731074 @default.
- W2078227270 cites W2142226485 @default.
- W2078227270 cites W2143708013 @default.
- W2078227270 cites W2143852804 @default.
- W2078227270 cites W2145693683 @default.
- W2078227270 cites W2146234408 @default.
- W2078227270 cites W2147941727 @default.
- W2078227270 cites W2156082602 @default.
- W2078227270 cites W2157673308 @default.
- W2078227270 cites W2165494158 @default.
- W2078227270 cites W2166224440 @default.
- W2078227270 cites W2168202400 @default.
- W2078227270 cites W2168552292 @default.
- W2078227270 cites W2170453842 @default.
- W2078227270 doi "https://doi.org/10.4103/2045-8932.105031" @default.
- W2078227270 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3555413" @default.
- W2078227270 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23372927" @default.
- W2078227270 hasPublicationYear "2012" @default.
- W2078227270 type Work @default.
- W2078227270 sameAs 2078227270 @default.
- W2078227270 citedByCount "94" @default.
- W2078227270 countsByYear W20782272702012 @default.
- W2078227270 countsByYear W20782272702013 @default.
- W2078227270 countsByYear W20782272702014 @default.
- W2078227270 countsByYear W20782272702015 @default.
- W2078227270 countsByYear W20782272702016 @default.
- W2078227270 countsByYear W20782272702017 @default.
- W2078227270 countsByYear W20782272702018 @default.
- W2078227270 countsByYear W20782272702019 @default.
- W2078227270 countsByYear W20782272702020 @default.
- W2078227270 countsByYear W20782272702021 @default.
- W2078227270 countsByYear W20782272702022 @default.
- W2078227270 countsByYear W20782272702023 @default.
- W2078227270 crossrefType "journal-article" @default.
- W2078227270 hasAuthorship W2078227270A5031013450 @default.
- W2078227270 hasAuthorship W2078227270A5047479690 @default.
- W2078227270 hasAuthorship W2078227270A5053967967 @default.